Report of a mission 20–24 April 2015
Results of the first national survey, 2013–2014
Learning from the Use of Data, Information, and Digital Technologies in the West Africa Ebola Outbreak Response
Human Rights, Minimum Standards and Monitoring at the European and International Levels
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Towards gender - transformative HIV and TB responses
На пути к гендерно-преобразовательным мерам против ВИЧ и ТБ
Health and Human Rights Journal
December 2016 / Volume 18 / Number 2 / Papers, 171-182
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
Rapport sur les populations clés.
Editorial
Rev Panam Salud Publica 40(6), 2016
Overview
Rev Panam Salud Publica 40(6), 2016
The END TB Strategy
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных наркотиков
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0